Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 21.23%
March 31, 2026 24.30%
December 31, 2025 22.53%
September 30, 2025 23.21%
June 30, 2025 22.69%
March 31, 2025 24.29%
December 31, 2024 25.20%
September 30, 2024 25.45%
June 30, 2024 25.47%
March 31, 2024 24.84%
December 31, 2023 19.17%
September 30, 2023 24.69%
June 30, 2023 23.35%
March 31, 2023 22.98%
December 31, 2022 23.99%
September 30, 2022 22.96%
June 30, 2022 24.10%
March 31, 2022 23.60%
December 31, 2021 23.97%
September 30, 2021 24.40%
June 30, 2021 24.98%
March 31, 2021 26.40%
December 31, 2020 24.63%
September 30, 2020 21.63%
June 30, 2020 21.47%
Date Value
March 31, 2020 27.19%
December 31, 2019 27.64%
September 30, 2019 28.60%
June 30, 2019 28.72%
March 31, 2019 26.02%
December 31, 2018 27.18%
September 30, 2018 28.04%
June 30, 2018 29.22%
March 31, 2018 26.01%
December 31, 2017 29.35%
September 30, 2017 29.33%
June 30, 2017 29.35%
March 31, 2017 24.73%
December 31, 2016 24.68%
September 30, 2016 27.12%
June 30, 2016 26.52%
March 31, 2016 26.23%
December 31, 2015 21.90%
September 30, 2015 34.29%
June 30, 2015 32.27%
March 31, 2015 31.44%
December 31, 2014 32.58%
September 30, 2014 32.70%
June 30, 2014 32.87%
March 31, 2014 31.85%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Lantheus Holdings, Inc. 62.30%
Globus Medical, Inc. 65.92%
Neogen Corp. 37.59%
Abbott Laboratories 52.64%
AngioDynamics, Inc. 50.87%